NUVATION BIO INC (NUVB:NYSE)
$4.76 -0.01 (-0.2096%)
Analysed NUVATION BIO INC (NUVB:NYSE) News Sources
Nuvation Bio to Participate in Upcoming Investor Conferences
02-09-2026
yahoo.com
Jim Cramer sends strong 5-word message on surging biotech stock
06-09-2026
thestreet.com
Nuvation Bio Announces New Analyses Reinforcing the Durable, Consistent Efficacy of IBTROZI® (taletrectinib) Across Key Patient Subgroups in Advanced ROS1+ NSCLC at 2026 World Conference on Lung Cancer
15-09-2026
yahoo.com
Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer
17-09-2026
yahoo.com
Top Penny Stocks To Own In October 2026
03-10-2026
yahoo.com
Top 3 Penny Stocks To Watch In October 2026
11-10-2026
yahoo.com
Nuvation Bio And 2 Penny Stocks To Watch
18-10-2026
yahoo.com
Nuvation Bio to Report Third Quarter 2026 Financial Results and Provide Business Update on November 4, 2026
21-10-2026
yahoo.com
Nuvation Bio And 2 More Penny Stocks To Watch
24-10-2026
yahoo.com
Nuvation Bio to Expand Pivotal Phase 3 SIGMA Study of Safusidenib for IDH1-Mutant Glioma to Six European Countries
29-10-2026
yahoo.com
What is the current price of NUVATION BIO INC (NUVB:NYSE)?
The current price of NUVATION BIO INC (NUVB:NYSE) is $4.76.
NUVATION BIO INC (NUVB:NYSE) absolute price change since previous trading day?
The absolute price change of NUVATION BIO INC (NUVB:NYSE) since the previous trading day is $-0.01.
NUVATION BIO INC (NUVB:NYSE) percentage price change since previous trading day?
The percentage price change of NUVATION BIO INC (NUVB:NYSE) since the previous trading day is -0.2096%.
What is the most recent average sentiment score for NUVATION BIO INC (NUVB:NYSE)?
The most recent average sentiment score for NUVATION BIO INC (NUVB:NYSE) is 78 out of 100.
What is the most recent average sentiment for NUVATION BIO INC (NUVB:NYSE)?
The most recent sentiment for NUVATION BIO INC (NUVB:NYSE) is .
SEC-8K** Filing Available For NUVATION BIO INC (NUVB:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.